Clinical use of anti-TNF therapy and increased risk of infections

Biologics such as antitumor necrosis factor (anti-TNF) drugs have emerged as important agents in the treatment of many chronic inflammatory diseases, especially in cases refractory to conventional treatment modalities. However, opportunistic infections have become a major safety concern in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Tauseef, Kaitha, Sindhu, Mahmood, Sultan, Ftesi, Abdul, Stone, Jordan, Bronze, Michael S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615849/
https://www.ncbi.nlm.nih.gov/pubmed/23569399
http://dx.doi.org/10.2147/DHPS.S28801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615849/
https://www.ncbi.nlm.nih.gov/pubmed/23569399
http://dx.doi.org/10.2147/DHPS.S28801

Ejemplares similares